EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

ALOX15 mediates thrombin‐induced myristoylation, trafficking, and interaction of protease‐activated receptors, leading to platelet activation and hemostasis

Suresh Govatati, Chandra Sekhar Yadavalli, Md Monirul Hoque, Swapna Thota, Gadiparthi N Rao iD

The FEBS Journal · 2026-11 · 293 (21) · 6323-6348

DOI: 10.1111/febs.70530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, online erschienen am 30.03.2026. Verfasst von Suresh Govatati und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, University of Tennessee Health Science Center, Memphis, TN, USA. Hauptthemen laut MEDLINE: Thrombin, Platelet Activation, Arachidonate 12-Lipoxygenase, Arachidonate 15-Lipoxygenase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of 12/15‐lipoxygenase (12/15‐LOX; polyunsaturated fatty acid lipoxygenase ALOX15) in platelet function is not known. Using knockout mice as well as pharmacological and molecular approaches, here we show for the first time that genetic deletion of 12/15‐LOX suppresses thrombin‐induced proteinase‐activated receptor 4 (PAR4) myristoylation and trafficking, causing a reduction in its interaction with proteinase‐activated receptor 3 (PAR3) in mouse platelets. We also found that 12/15‐LOX, via activation of protein kinase C theta (PKCθ), mediates N‐myristoyltransferase 1 (NMT1) phosphorylation, which modulates thrombin‐induced PAR4 myristoylation, trafficking, and its interaction with PAR3, leading to PAR3/4 heterodimer formation in mouse platelets. In line with these observations, genetic deletion or inhibition of 12/15‐LOX or pharmacological blockade of PKCθ or NMT1 attenuated thrombin‐induced PAR4 myristoylation, trafficking, and its interaction with PAR3, leading to reduced platelet activation in mouse platelets. Similarly, mice with genetic deletion or inhibition of 12/15‐LOX or blockade of PKCθ or NMT1 exhibited a prolonged bleeding time and delayed clotting and clot retraction times. Intriguingly, we found that thrombin induces myristoylation, trafficking, and thereby dimerization of both PAR1 and PAR4 in human platelets, and inhibition of 15‐LOX1, the human orthologue of murine 12/15‐LOX, attenuated these effects. Following these observations, inhibition of 15‐LOX1 blunted thrombin‐induced platelet activation and clot retraction in humans. Thus, our findings unfold an essential role for 12/15‐LOX in thrombin‐induced platelet activation and hemostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombinPlatelet ActivationArachidonate 12-LipoxygenaseArachidonate 15-LipoxygenaseHemostasisBlood PlateletsReceptors, ThrombinAnimalsMiceProtein Kinase C-thetaMice, KnockoutProtein TransportProtein Kinase CHumansPhosphorylationReceptors, Proteinase-Activated

Stichwörter der Autor:innen

12/15‐lipoxigenasehemostasismyristoylationprotease‐activated receptorprotein kinase C

Substanzen

ThrombinProtein Kinase C-thetaArachidonate 12-LipoxygenaseArachidonate 15-LipoxygenaseProtein Kinase CReceptors, ThrombinPrkcq protein, mouseprotease-activated receptor 3protease-activated receptor 4, mouseprotease-activated receptor 4

Autor:innen und Institutionen

  • Department of Physiology, University of Tennessee Health Science Center, Memphis, TN, USA.
  • College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, TN, USA.
  • Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.

ORCID-Profile: Gadiparthi N Rao

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Govatati, S., Yadavalli, C. S., Hoque, M. M., Thota, S., & Rao, G. N. (2026). ALOX15 mediates thrombin‐induced myristoylation, trafficking, and interaction of protease‐activated receptors, leading to platelet activation and hemostasis. The FEBS Journal, 293(21), 6323-6348. https://doi.org/10.1111/febs.70530

Vancouver

Govatati S, Yadavalli CS, Hoque MM, Thota S, Rao GN. ALOX15 mediates thrombin‐induced myristoylation, trafficking, and interaction of protease‐activated receptors, leading to platelet activation and hemostasis. The FEBS Journal. 2026;293(21):6323-6348. doi:10.1111/febs.70530

BibTeX
@article{Govatati2026,
  author = {Govatati, Suresh and Yadavalli, Chandra Sekhar and Hoque, Md Monirul and Thota, Swapna and Rao, Gadiparthi N},
  title = {ALOX15 mediates thrombin‐induced myristoylation, trafficking, and interaction of protease‐activated receptors, leading to platelet activation and hemostasis},
  journal = {The FEBS Journal},
  year = {2026},
  volume = {293},
  number = {21},
  pages = {6323--6348},
  doi = {10.1111/febs.70530}
}
Kostenlos starten →